LOXL2 inhibitors (InterMune)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameLOXL2 inhibitors (InterMune)

Drug Alias Namelysyl oxidase-like protein 2 inhibitors (InterMune)ITMN-15376

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLysyl oxidase homolog 2 inhibitors

TargetsLysyl oxidase homolog 2

Therapy Area/IndicationsFibrosisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIntermune Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIntermune Inc

Active IndicationsN/A

Inactive IndicationsFibrosisNeoplasms

ATC CodeN/A